Alcon, the eye care business of Novartis, has announced plans...

Alcon, the eye care business of Novartis, has announced plans to locate its future global headquarters in Geneva once its proposed spinoff from Novartis International is complete. The Swiss group decided to cut ties with Alcon in July, to focus on its portfolio of pharmaceutical products (see Eyewear Intelligence, Vol. ...

You need to register to continue reading this article

Already subscribe to Eyewear intelligence? Sign in here

Register to continue reading

By registering today you will have access to:

  • 3 industry news articles per month

For full access and to receive in-depth news, analysis and more, become a member today

For more content and resources become a member? View our membership packages.